These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27162099)

  • 1. Genetic and epigenetic heterogeneity in acute myeloid leukemia.
    Li S; Mason CE; Melnick A
    Curr Opin Genet Dev; 2016 Feb; 36():100-6. PubMed ID: 27162099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia.
    Li S; Garrett-Bakelman FE; Chung SS; Sanders MA; Hricik T; Rapaport F; Patel J; Dillon R; Vijay P; Brown AL; Perl AE; Cannon J; Bullinger L; Luger S; Becker M; Lewis ID; To LB; Delwel R; Löwenberg B; Döhner H; Döhner K; Guzman ML; Hassane DC; Roboz GJ; Grimwade D; Valk PJ; D'Andrea RJ; Carroll M; Park CY; Neuberg D; Levine R; Melnick AM; Mason CE
    Nat Med; 2016 Jul; 22(7):792-9. PubMed ID: 27322744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights.
    Claus R; Plass C; Armstrong SA; Bullinger L
    Future Oncol; 2010 Sep; 6(9):1415-31. PubMed ID: 20919827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic targeting and personalized approaches for AML.
    Roboz GJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.
    Xu J; Hang X; Wu B; Chen C; Liu Y
    Adv Exp Med Biol; 2019; 1143():173-189. PubMed ID: 31338820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML.
    Li S; Chen X; Wang J; Meydan C; Glass JL; Shih AH; Delwel R; Levine RL; Mason CE; Melnick AM
    Cancer Discov; 2020 Dec; 10(12):1934-1949. PubMed ID: 32938585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission.
    Corces-Zimmerman MR; Hong WJ; Weissman IL; Medeiros BC; Majeti R
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2548-53. PubMed ID: 24550281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia.
    Majeti R
    Best Pract Res Clin Haematol; 2014; 27(3-4):229-34. PubMed ID: 25455271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
    Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
    Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aberrant DNA methylation and its targeted therapy in acute myeloid leukemia].
    Li X; Zhu L; Ye X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):387-394. PubMed ID: 27868412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic determinants of AML pathogenesis.
    Cai SF; Levine RL
    Semin Hematol; 2019 Apr; 56(2):84-89. PubMed ID: 30926095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse.
    Tan Y; Liu H; Chen S
    Front Med; 2015 Dec; 9(4):412-20. PubMed ID: 26482067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
    Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
    J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
    Boila LD; Sengupta A
    Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increasing genomic complexity of acute myeloid leukemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2014; 27(3-4):209-13. PubMed ID: 25455268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
    Grove CS; Vassiliou GS
    Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations in acute myeloid leukemias.
    Mehdipour P; Santoro F; Minucci S
    FEBS J; 2015 May; 282(9):1786-800. PubMed ID: 25369368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterogeneity and clonal evolution in acute myeloid leukemia.
    Romer-Seibert JS; Meyer SE
    Curr Opin Hematol; 2021 Jan; 28(1):64-70. PubMed ID: 33186150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.
    Zhang X; Lv D; Zhang Y; Liu Q; Li Z
    Oncotarget; 2016 Sep; 7(36):58586-58594. PubMed ID: 27474172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.